MGRXMANGOCEUTICALS, INC.

Nasdaq www.mangorx.com


$ 0.22 $ -0.03 (-12.36 %)    

Tuesday, 14-May-2024 15:58:02 EDT
QQQ $ 445.88 $ 2.85 (0.64 %)
DIA $ 395.58 $ 1.12 (0.28 %)
SPY $ 523.16 $ 2.39 (0.46 %)
TLT $ 90.86 $ 0.51 (0.56 %)
GLD $ 218.12 $ 1.83 (0.85 %)
$ 0.219099
$ 0.23
$ 0.00 x 0
$ 0.00 x 0
$ 0.22 - $ 0.23
$ 0.14 - $ 2.38
111,135
na
3.53M
$ -3.37
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 04-01-2024 12-31-2023 10-K
2 10-27-2023 09-30-2023 10-Q
3 07-28-2023 06-30-2023 10-Q
4 05-10-2023 03-31-2023 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 mangorx-acquires-patent-portfolio-for-total-of-20m-through-issuance-of-980k-of-6-series-c-convertible-preferred-shares

Mangoceuticals, Inc. (NASDAQ: MGRX) ("MangoRx" or the "Company"), a company focused on developing, marketing, a...

 mangoceuticals-subsidiary-mangorx-mexico-executes-technical-agreement-with-mexican-pharmaceutical-manufacturer-for-initial-development-and-production-of-its-mango-erectile-dysfunction-products

Signifies the first major step towards the application process for the certification of itsMango ED oral dissolvable products b...

 why-salarius-pharmaceuticals-shares-are-trading-higher-by-around-31-here-are-20-stocks-moving-premarket

Shares of Salarius Pharmaceuticals, Inc. (NASDAQ: SLRX) rose sharply in today’s pre-market trading following fourth-quarter re...

 why-taysha-gene-therapies-shares-are-trading-higher-by-around-27-here-are-20-stocks-moving-premarket

Shares of Taysha Gene Therapies, Inc. (NASDAQ: TSHA) rose sharply in today’s pre-market trading after the company reported a y...

 mangorx-launches-prime-by-mangorx-powered-by-kyzatrex-fda-approved-oral-testosterone-replacement-therapy-treatment

The Dallas Based, Direct-to-Consumer Telemedicine Company Brings the FDA-Approved Oral Testosterone Replacement Therapy Treatme...

 mangorx-launches-direct-to-clinics-sales-division

Newly developed clinic prescribing system will allow Doctors to prescribe MangoRx products from within practices and clinics

 why-compass-minerals-international-shares-are-trading-lower-by-around-9-here-are-other-stocks-moving-in-thursdays-mid-day-session

Shares of Compass Minerals International, Inc. (NYSE: CMP) fell sharply during Thursday’s session following downbeat results.

 why-disney-shares-are-trading-higher-by-around-6-here-are-20-stocks-moving-premarket

Shares of The Walt Disney Company (NYSE: DIS) rose in today’s pre-market trading following the release of quarterly results.

 mangorx-accepting-pre-orders-for-its-prime-by-mangorx-powered-by-kyzatrex-fda-approved-oral-testosterone-replacement-therapy-product

The Dallas Based, Direct-to-Consumer Telemedicine Company to Offer 2 Months of Free ‘PRIME' by MangoRx, Powered by Kyzatrex...

 why-quanex-building-products-shares-are-trading-lower-by-over-10-here-are-other-stocks-moving-in-fridays-mid-day-session

Shares of Quanex Building Products Corporation (NYSE: NX) moved lower during Friday’s session after the company reported fourth...

 mangoceuticals-inc-announces-pricing-of-12m-public-offering-of-4m-shares-of-common-stock-at-a-price-of-030-per-share

Mangoceuticals, Inc. (NASDAQ:MGRX) ("MangoRx" or the "Company"), a company focused on developing, marketing, an...

 why-getaround-shares-are-trading-higher-by-around-86-here-are-20-stocks-moving-premarket

Shares of Getaround, Inc. (NYSE: GETR) rose sharply in pre-market trading after the company reported a year-over-year increas...

 mangoceuticals-on-dec-10-entered-into-a-marketing-agreement-with-marius-pharmaceuticals-agreement-allowing-co-the-use-of-trademark-kyzatrex-oral-testosterone-undecanoate-softgel-capsules-agreement-allowing-co-selling-kyzatrex-on-their-website

-SEC 8K Filing

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION